STAGE II NON-SMALL CELL LUNG CANCER: UPFRONT SURGERY OR NEOADJUVANT CHEMOIMMUNOTHERAPY
Listen to this summary
The authors investigate whether neoadjuvant chemoimmunotherapy offers better overall survival compared to upfront surgery in stage-II non-small cell lung cancer patients. Their analysis reveals that while neoadjuvant chemoimmunotherapy improves survival compared to surgery in the 8th edition TNM database, results are similar in the 9th edition. Additionally, chemoimmunotherapy shows superior pathological response rates and event-free survival compared to chemotherapy, although surgical outcomes remain comparable.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from The Annals of thoracic surgery
View all →Jun 11, 2026 · The Annals of thoracic surgery
Risk and Outcomes of Reintervention After Transcatheter Aortic Valve Implantation
Jun 9, 2026 · The Annals of thoracic surgery
Graft-Assisted Transapical Transcatheter Aortic Valve Replacement with Concomitant Robotic Minimally Invasive Direct Coronary Artery Bypass
Jun 9, 2026 · The Annals of thoracic surgery
Preoperative Resting Heart Rate and 30-Day Heart Failure After Off-Pump Coronary Artery Bypass Grafting
More in Thoracic Surgery (Cardiothoracic Vascular Surgery)
View all →Sep 23, 2026 · JAMA
Tenecteplase Before Thrombectomy at 4.5 to 24 Hours for Basilar Artery Occlusion: The ATTENTION LATE Randomized Clinical Trial
Sep 23, 2026 · The New England journal of medicine
Clinical Uses of Common Genetic Variants Associated with Common Diseases
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · The New England journal of medicine
Etuvetidigene Autotemcel for the Treatment of Wiskott-Aldrich Syndrome
Sep 22, 2026 · Lancet (London, England)
Understanding peripheral arterial disease in the current era
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
